420 with CNW — Michigan Registers a Record-Setting $261M in June Cannabis Sales

420 with CNW — Michigan Registers a Record-Setting $261M in June Cannabis Sales

image

June witnessed a remarkable achievement in marijuana sales in Michigan as the figures soared to an unprecedented peak, nearing a staggering $261 million. The lion’s share of this impressive total, amounting to $254,153,133, was contributed by adult-use marijuana purchases, while medical cannabis sales reached $6,643,877. This remarkable feat exceeded the previous record set in March by a margin of more than $10 million.

According to data from the Michigan Cannabis Regulatory Agency (CRA), the majority of cannabis purchases consisted of flowers, followed closely by vape cartridges and infused edibles.

Despite these remarkable sales records, Michigan continues to witness a noteworthy decline in the average cost of marijuana. The price of an ounce of recreational cannabis now lingers around $90, a substantial decrease compared to December 2021, when it was approximately $180. Similarly, the average ounce of medical marijuana in the previous month was valued at about $100.

While the cannabis market in Michigan continues to mature, businesses face persistent challenges due to federal prohibition. The absence of access to traditional financial services has forced the industry to rely heavily on cash transactions, making it an attractive target for criminal activities.

Highlighting the urgency of addressing this issue, the attorney general of Michigan emphasized the need for Congress to enact marijuana banking reform.

Last year, Michigan regulators unveiled their commitment to fund research on the therapeutic benefits of marijuana for military veterans by allocating tax revenue generated from adult-use cannabis sales. This time, the CRA recommended granting $20 million to two universities as part of the Veteran Marijuana Research (VMR) Grant Program. Additionally, officials announced the distribution of nearly $150 million in marijuana tax revenue to various beneficiaries, including a transportation grant, public schools and localities.

In recent developments, state officials in Michigan changed the state’s employment policy, eliminating pre-employment drug testing for marijuana for most government job applicants. This adjustment reflects a progressive stance toward cannabis use.

Michigan is not the only state experiencing remarkable growth in cannabis sales. Massachusetts achieved record-breaking marijuana sales of nearly $152 million in June, marking the highest monthly figure since the state’s adult-use market was launched in November 2018. Similarly, Connecticut witnessed a surge in marijuana sales, reaching a record high of $24 million in the six months following the launch of its recreational cannabis industry.

In Maryland, where the adult-use cannabis market began this month, marijuana sales surpassed $10 million during the opening weekend, indicating a promising start for the industry in the state.

These soaring sales figures coming out of Michigan suggest that it isn’t only marijuana companies that are benefiting from this boom. Ancillary companies such as Advanced Container Technologies Inc. (OTC: ACTX) may also be seeing an increase in business.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Aurora Cannabis closes sale of Sun facility

Aurora Cannabis closes sale of Sun facility

Aurora Cannabis has closed the sale of its Medicine Hat, Alberta facility to Bevo Farms, a subsidiary of Bevo Agtech Inc.

The facility, dubbed Aurora Sun, was to be a 1.63 million square foot cannabis greenhouse, but construction was suspended in late 2019. Aurora said they would only build approximately 238,000 square of the 1.63M square foot facility by 2020, with the rest completed when market conditions improved.

The Aurora Sun Facility was sold via Bevo Farms’ acquisition of one of Aurora’s wholly-owned subsidiaries. Aurora has a controlling interest in Bevo as of 2022. Founded in 1986, Bevo operates 63 acres of greenhouse in British Columbia.

Bevo could pay “up to” $15 million to Aurora in connection with the Aurora Sun transaction as long as Bevo Farms successfully achieves specific financial milestones at the Aurora Sun facility.

“I am pleased that this transaction will achieve the dual objectives of improving Aurora’s cash flow, while benefiting Bevo as they proceed with the expansion of their business,” said Aurora’s CEO Miguel Martin in a press release.

Leo Benne, CEO of Bevo, added, “Bevo’s ability to deliver propagated plants directly from Medicine Hat to the Alberta greenhouse industry and beyond delivers a win for the Alberta greenhouse industry, the City of Medicine Hat and its residents, for Bevo, and for Aurora. We would like to express our gratitude to the City of Medicine Hat for their essential contributions to this transaction. We look forward to further developing our partnerships in Alberta in the years to come.”

Other facility closures

Aurora announced the sale of another facility in Alberta, Aurora Polaris earlier this year

Originally located next to the now-defunct Aurora Sky facility, the company first announced the plans for a 300,000 square foot Polaris project in 2019, at an estimated cost of $50 million. The building was originally intended to serve as Aurora’s “centre of excellence for the industrial-scale production of higher margin, value added products, such as edibles.”

In May 2022, Aurora announced the closure of Aurora Sky, with 214 lost jobs. Martin points out that Bevo had already taken over the Aurora Sky facility.

 “Bevo has successfully repurposed the Aurora Sky facility in Edmonton, and we’re excited to further support their continued growth. Bevo’s acquisition of the Aurora Sun facility further demonstrates the close synergies between our companies and the value that our partnership creates for shareholders.”

In September 2021, the company announced their plans to close the Polaris facility, representing a loss of eight percent of its global workforce. A news report at the time noted an Alberta government website listed the Aurora Polaris facility as being around 2,800 square meters “with one-third of the space dedicated to warehousing and distribution of cannabis products and the remainder hosting product manufacturing.”

In 2022, Aurora closed down a 200-acre “Aurora Valley” cannabis farm in BC. A spokesperson for Aurora Cannabis told StratCann at the time that the Thrive Cannabis location replaced the need for the Aurora Valley site.

In 2020, Aurora sold a massive Ontario greenhouse for $17 million, which it had inherited when the company acquired medical cannabis producer MedReleaf. In their most recent quarterly report, Aurora reported a net loss of $87 million.


New Research Suggests Psychedelic Helplines Could Avert Possible Harms

New research analyzing psychedelic use in nonclinical settings has found that creating psychedelic helplines could help alleviate the potential harms of recreational psychedelic use. Researchers behind the recent study were concerned with the lack of safety protocols for psychedelic use in nonclinical settings as recreational psychedelic use is on the rise among Americans.

Psychedelics have captured the scientific community and the mainstream public’s attention due to their potential mental health benefits. A growing body of research has revealed that psychedelics can treat a myriad of mental health conditions with few side effects and offer long-term relief to patients who didn’t respond positively to traditional treatments.

However, even though hallucinogenics are still illegal at the federal level and in most states, they have attracted a small community of users for decades. Now that scientific research has shown that psychedelics may have mental health benefits, even more people are using them outside of a clinical setting.

While some people have benefitted from incorporating psychedelics into their wellness routines, the risk of negative health outcomes is significant, especially for drugs such as ketamine, which can be fatal in high doses. In addition, although psychedelics such as psilocybin may not be as dangerous as ketamine, psychedelic abuse can cause side effects such as impaired muscle coordination (ataxia), dizziness and muscle weakness. Psychedelic abuse may also cause emotional and psychological issues, including anxiety, depression and poor motivation.

The researchers wanted to find ways to limit the risks associated with recreational psychedelic use, such as leveraging already existing peer support systems that provide support on matters such as mental health and harm reduction.

Mollie M. Pleet, a licensed psychologist as well as a social neuroscience and psychotherapy lab member and study author, said that she has spent the past few years as part of a team that helps people deal with emotional, spiritual and psychological issues arising from psychedelic use.

Pleet explained that this experience showed her firsthand just how powerful peer support can be at aiding people affected negatively by nonclinical psychedelic use. She and her team obtained confirmation from the Fireside Project, a nonprofit organization that runs a psychedelic helpline for people living in psychedelic states.

The team found that callers often experienced emotions such as anxiety, confusion and fear as well as being overwhelmed. The results showed that 27.4% of the callers reported having an underlying psychiatric condition and the majority of callers (77%) said they had most of their psychedelic experiences at home by themselves.

Researchers noted that psychedelic helplines could be especially helpful to this majority who use psychedelic at home with no one around to support them during the experience. They concluded that psychedelic helplines showed promise in helping callers under the influence or with a history of psychedelic use to manage emotional challenges and safety issues.

That being said, it is noteworthy that a vast majority of startups that are developing psychedelics formulation, such as Field Trip Health Ltd. (OTC: FTHWF) (TSX: FTHW), are looking to avail those treatments through a clinical setting rather than investing in the development of recreational or self-prescribed products. The intention is to limit the potential risks that these potent substances could have for users.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

5 years of learning: An anniversary tribute to cannabis

5 years of learning: An anniversary tribute to cannabis

October 2023 marks the five-year anniversary of legal cannabis in Canada, and last Fall,  Grow Opportunity also saw five years covering this industry. In honour of the occasion, for us and for our nation, we present a retrospective spin on the past handful of years with experts’ views on how to incorporate all all we’ve learned since 2018.    

The sections assessed herein include regulatory comments by consultant Mitchell Osak, cultivation and production insight by grower and consultant David Kjolberg and covering retail, Jaclynn Pehota, executive director of the Retail Cannabis Council of British Columbia (RCCBC), points out a bright spot in this industry: the triumphant small business owners in B.C.       

Mitchell Osak on regulatory challenges

The regulatory hurdles in the Canadian cannabis market imposed by Health Canada and the federal and provincial governments combined create a minefield for licensed cannabis producers who, “today, can be paying as much as 33 per cent of their sales revenue in taxes and fees,” writes Osak, in an email to Grow Opportunity. While cannabis in Canada is federally legal, “there are a myriad of market structures, wholesaler mark-ups and policies that vary from province to province. This necessitates different strategies, thereby complicating life and raising the cost for LPs,” he says. 

“The issue of regulatory inconsistencies between jurisdictions is a major challenge affecting this industry and its ability to turn a profit,” continues Osak. And regulations related to the onerous level of excise taxes will only shift if the CRA plus all provinces/territories agree to relinquish a portion of their revenue and alleviate the financial conditions impairing LP operations.

Advertisement

Furthermore, restrictions on THC in edibles have neglected consumer needs for higher potency products and stunted potential demand, “sending users back to the untested unregulated market” – the public health implications of which are evident yet ill-addressed. 

For the past five years, industry players have acquired essential knowledge and lessons learned enabling them to produce better products at lower costs. Osak now advises clients to “choose a strategic lane and execute with excellence.” Maintaining a profitable business, he says, depends on “aligning your operating model and capacity to your actual market demand and channel needs, because eschewing humility and the ‘build it and they will come’ model is a recipe for failure.” 

Osak affirms that successful LPs understand the above winning formula is part “art and science.” The art includes “innovation, maximizing human capital and learning from your peers,” while the science could involve using “data analytics to make better operational and marketing decisions, prudently managing cash and staying close to your consumers’ changing needs.”

Though rest assured, “there is still plenty of growth left in the Canadian market,” says Osak. As much as 50 per cent or more than today. “This growth will be driven by higher consumption by existing and new users coming in from the illicit market, enticed by a greater selection of higher quality and cost competitive products that deliver 100 per cent on user needs. LP revenue growth will also be propelled by greater sales in international medical and emerging adult-use markets.”

As an unfortunate yet consistent business truth concerning nascent industry contraction, fortunately those “budding entrepreneurs now entering the market can learn from their first-moving peers.” They may employ asset-lite strategies, such as “outsourcing production while focusing on genetics curation or brand building,” writes Osak. “And after the industry goes through its inevitable shakeout of LPs and retailers, new market opportunities are likely to appear,” he concludes.  

David Kjolberg on cannabis production

While working as the master grower for Peace Naturals from 2014-2017, on the eve of legalization, Kjolberg recalls the swaths of tour groups requesting to come through the facility. A group of four would arrive, “and you’d have your grower, your lawyer, your accountant, and another c-suite exec, and they would be most interested in asking about scaling,” says Kjolberg, in a phone conversation with Grow Opportunity. 

“You’d see the accountant’s eyes widen after he’d do the math because on paper, it looks like they’re going to be rich,” he continues. “And that was the problem! It all started because everybody was focused on growing spreadsheets instead of quality flower.”

Kjolberg points to the challenges producers ran into through a lack of consideration for factors such as powdery mildew, Hop Latent Viroid or the unfamiliarity of genetics with different requirements. This proved problematic for some in upper management who didn’t understand the plant or the culture that came with it.  

Some of the bigger LPs, he says, likely had a grower with some good credentials who wrote the SOPs. “And after they’re gone, they’d keep using the SOPs and then end up with product they can’t sell because it’s a bunch of dry popcorn nuggets that’s not been cured properly,” says Kjolberg. “Cannabis, anywhere between 10.5 or 12 per cent moisture – you know you’ve got a nice enjoyable smoke,” he adds. “But when it gets down to five or six per cent, you’ve got problems. And consequently, the drier it is, the better the test result.” 

The advancements in cannabis production over the years has been paramount. “What’s changed over the last five years is technology,” says Kjolberg. “Crop steering, using sensors in your grow, is very important. HVAC systems have gotten very good, lighting is getting very good,” he says. “So, by the use of automation, we’re able to know where we stand in our grow rooms.” 

“But the biggest factor of what’s changed,” says Kjolberg, “came with the nursery licenses – it’s the availability of genetics and tissue culture.” In a 2,300-square-foot facility, real estate is reserved for flowering rather than mothering and cloning. Producers can purchase excellent genetics from nurseries as clones or as teens. “It’s plug and play, and it’s guaranteed,” he says. 

“When I first started, you had what you brought with you. A bunch of seeds or plants you had when you first got your license,” he says. “And now with AI and automation, the best grow rooms are the ones you stay the hell out of.” 

Some changes Kjolberg would like to see sweep this industry from a retail perspective include heightening the sensory aspect of cannabis sales, as in sight and smell, which informs consumers by drawing attention to the flavour and terpene profile of products. He’d also like to see increased budtender wages and better relationship-building between buyers and producers.  

For those producers now entering the market, a hands-on approach to brand building based on great genetics, while refraining from being top-heavy in management, Kjolberg suggests, is the right way to go. The next wave of entrepreneurs “should be lean and produce great flower that pays the bills,” says Kjolberg. “When you know your next harvest is only two weeks away, that’s the optimal place to be.”  

Effectively predating both Grow Opportunity and the legal market is Vancouver’s annual Sunset Beach Park 4/20 celebration (2016) complete with live music, full sun and free joints.
Photo: Haley Nagasaki

Jaclynn Pehota sees retail success in small business ownership

The unregulated market’s chokehold on this industry,    especially in categories like concentrates, continues nearly five years into the legalization of cannabis.. Store clusters in some areas and lack of access in others compound this issue in that some retailers forecast a similar contraction as the one being experienced by LPs. 

“There are situations with too many stores in an area for the population density and these challenges are redoubled by the most impactful issue: competition with the unregulated market,” writes Pehota, in an email to Grow Opportunity. 

“The last Stats Canada poll I saw had 50 per cent of Canadians that use cannabis self-reporting that they exclusively used the legal system. 50 per cent market capture amplifies the struggles of licensed retailers for obvious reasons. The legal market simply isn’t playing the game with a full deck of cards,” she says. “We can’t win with half the deck missing.” 

In addition to the lack of retail license capping in provinces like Ontario, other factors impede retailer success, such as “lack of understanding on the part of elected officials and overly onerous marketing restrictions.” 

But what is it that sets the East apart from the West? As executive director of the RCCBC advocacy group, Pehota sees circumstances in Ontario largely as “an aftershock of two factors: a speculative bubble driven by pubcos and significant regulator flip-flops that took the total number of stores in the province from 22-ish to over 200 in less than a year, and has expanded to over 1,800 since.” She points to the inability to differentiate in market because “all product is coming through the same public wholesaler, resulting in a race to the bottom on pricing.” 

In B.C., a slower approach to store growth meant that businesses had a better chance to establish themselves, and the direct delivery opportunities between retailers and small producers created specially curated opportunities with “exclusive lines of supply.” Therefore, the difference in the outcome between provinces, as she sees it, is “down to the original regulator mindset, industry organization and the direction of industry advocacy.” 

Successes as a result of B.C.’s more prudent cannabis retail development, the capping placed on store volume expansion and the profitable independent retailers, demonstrates what’s possible as we enter this next wave of regulated cannabis. 

“What has not been successful in B.C. has been the ongoing attempt by larger chains to buy market share in place of pursuing sustainable growth. You can’t ‘fake it ‘til you make it’ in this situation,” writes Pehota. “Recent bankruptcies demonstrate this very pointedly.” 

Western Canada is also leading the conversation around preventing loss and incidents by removing opaque window coverings in cannabis retail stores. As of June 23, Ontario is reconsidering its stance on this as well. 

Retailers that were perhaps lost in conversation – eclipsed by production – are now coming back around to the forefront, equipped with new datasets. Incorporating this knowledge could begin with a pivot away from the big pubco narrative in favour of privately owned successful small businesses, where in B.C., RCCBC represents 175 stores, or one-third of the total retail market. 

Village Farms to report second quarter 2023 financial results on August 9

(Globe Newswire) Vancouver — Village Farms International, Inc. will host a conference call to discuss its second quarter financial results on Wednesday, August 9, 2023, at 8:30 a.m. ET.

Participants can access the conference call via a webcast at Village Farms Second Quarter 2023 Conference Call Webcast or on the company website at Village Farms – Events. Participants wanting to access the conference call by telephone must register in advance at Village Farms Second Quarter 2023 Conference Call to receive telephone dial-in information.

The live question and answer session will be limited to analysts, however others are invited to submit their questions ahead of the conference call via email: investorrelations@villagefarms.com. Management will address questions received via email as part of the conference call question and answer session as time permits.

The company expects to report its second quarter 2023 financial results via news release on Wednesday August 9, 2023, at 7:00 a.m. ET.

Advertisement

Aurora CEO sees compensation rise to $6.7 million amid share slump, cost cutting

Edmonton — Aurora cannabis Inc.’s chief executive saw his annual compensation climb about 38 per cent to $6.7 million in the company’s latest fiscal year as its stock dramatically fell and it aggressively cut costs.

Financial filings from the Edmonton-based cannabis company show Miguel Martin earned a base salary of about $590,500 and about $3.8 million in share-based options and almost $1.1 million in option-based awards.

Rounding out his earnings was about $815,000 in non-equity incentive plan compensation and $416,000 in other compensation.

In comparison, he made more than $4.8 million in compensation in Aurora’s 2022 fiscal year and about $4.4 million in 2021.

Advertisement

Martin’s compensation boost came as Aurora’s share price fell by 52 per cent over its 2023 fiscal year, which spanned three quarters because the company changed its fiscal year end.

The cannabis industry has been hampered by a lack of demand, strict regulations and the strength of the illicit market for much of Martin’s time as chief executive. To cope, Aurora embarked on a transformation plan that delivered at least $400 million in savings over the last three years.

Michelle Lefler, Aurora’s vice-president of communications and public relations, said the company uses a “pay-for-performance approach” and most of Martin’s compensation is linked to Aurora’s share price and corporate performance metrics, which were either met or exceeded.

“It is important to make clear that long term incentives granted to executive leadership are entirely linked to the company’s share performance,” Lefler said in an email.

“Today, the value of these rewards is much lower than the value at which they were originally granted.”